Trial intelligence / Profile preview

Remimazolam for induction and maintenance of general anesthesia in abdominal laparoscopic surgery (vs propofol)

ChiCTR2600119420Phase 4Recruiting

Sponsor
The First Affiliated Hospital of USTC
Start
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam (3 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoints: MOAA/S score, Bispectral Index (BIS) and 2 more. Started Feb 2026; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2600119420.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600119420.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call